Abolis Biotechnologies
Custom biotech industrial solutions
- B2B
About Abolis Biotechnologies
Develops tailor-made industrial solutions using microorganisms for various sectors, addressing challenges like renewable resources, supply chain security, and emissions reduction.
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Évry, Île-de-France, France
- Founded
- 2014
- Revenue
- $8.9M – $70.7MTamtam estimate
- Website
- abolis.fr
Abolis Biotechnologies in the news
- French Tech : Abolis, spécialiste de la biologie de synthèse - 17/11
Cyrille Pauthenier of Abolis Biotechnologies discussed their tailored industrial solutions using natural or modified microorganisms on French Tech.
- Abolis et EuroAPI vont mêler biotech et chimie pour produire des corticoïdes à 100 % européens
Abolis Biotechnologies and EuroAPI collaborate to develop fully European-produced corticoids by combining biotech and chemistry, aiming to reduce dependence on Asian suppliers.
- Synbio alliance strengthens EU corticosteroid supply chain
A €140 million EU-backed alliance including Abolis Biotechnologies is developing AI-enhanced synthetic biology processes to produce corticosteroids locally and reduce reliance on Asian imports.
- Euroapi et Abolis Biotechnologies engagent un partenariat stratégique
Abolis Biotechnologies and Euroapi form a strategic partnership to develop microbial strains for corticosteroid production, supported by a major EU health initiative to strengthen European pharmaceutical sovereignty.
- Euroapi et Abolis Biotechnologies engagent un partenariat stratégique...
Abolis Biotechnologies and Euroapi form a strategic partnership to develop microbial strains for corticosteroid production, supported by a major EU health initiative to strengthen European pharmaceutical sovereignty.
Abolis Biotechnologies at a glance
Abolis Biotechnologies is a B2B company in the Biotechnology Research industry, headquartered in Évry, Île-de-France, France.
Abolis Biotechnologies was founded in 2014.
Abolis Biotechnologies has 51–250 employees.
Abolis Biotechnologies's revenue is $8.9M – $70.7M (Tamtam estimate).
Selling to companies like Abolis Biotechnologies?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies